We should be that leading edge and we should have a system that accommodates it.
The Promising Pathway Act is a commonsense step to give the FDA the flexibility it needs to serve Americans with these m...
However, millions of Americans with these diseases still lack any FDA approved treatments.
Patients deserve a promising pathway at the FDA.
I have been working on this for most of the five-years I have been here in the Senate.
That is why we need the formality of PPA.
This is long overdue.
Thank you, Mr. Chairman. My pleasure to introduce Dr. Peggy Plews-Ogan.
The time is not the right amount of time, and the children are being ignored in this and it shouldn't be that way.
My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.
Thank you, Mr.